- Definition der medizinischen Indikation
- Abgrenzung zum Standard of Care
- Schutzfähige IP-Positionierung
- Early-Market-Validation
Our
Innovations.
From Concept to Patient – Structured, Secure
And Swift.
Medical innovation is never a coincidence – it is the result of structure, speed, and scientific excellence. PreviPharma has established an integrated development platform designed to transform medical concepts into clinical Proof-of-Concept data within just 12-24 months. We bridge the gap between research, clinical infrastructure, and IP strategy to create a seamless engine for innovation.
Our Innovation Principle
From Medical Need to Clinical Concept.
While traditional pharmaceutical developments often require 6-10 years to reach the first clinical signal, PreviPharma pursues a radically accelerated approach:
1.
Medical demand
2.
Preclinical proof
3.
Clinical PoF
4.
IP-Rating
5.
Partnership or out-licensing
Our
Innovation Platform
From Concept to Patient – Structured, Secure, Swift.
PreviPharma operates a fully integrated development environment.
It encompasses
Accelerated Candidate Development Process
PreviPharma operates a fully integrated development environment:
It includes:
INNOVATION THROUGH
IP-FIRST-STRATEGY
PreviPharma does not only develop active pharmaceutical ingredients — we develop IP assets.
Our value creation is based on:
This creates scalable, capital-efficient pharmaceutical assets with a clearly defined exit structure.
PreviPharma stands for a new generation of pharmaceutical innovation: scientifically sound, economically scalable, and clinically relevant, as the medicine of the future.
Talk to
Us.
Now.
We would be happy to provide you with further information and discuss the possibilities for cooperations with you.
Sie müssen den Inhalt von reCAPTCHA laden, um das Formular abzuschicken. Bitte beachten Sie, dass dabei Daten mit Drittanbietern ausgetauscht werden.
Mehr Informationen